AbstractPURPOSE:: To evaluate the safety and efficacy of treatment of severe infectious corneal ulcers with hypoosmolar riboflavin solution and UV-A collagen cross-linking (CXL) without deepithelizing the cornea. METHODS:: Four eyes of 3 patients with severe keratitis and associated corneal melting, were treated with a new protocol of corneal CXL for infectious keratitis, named cross-linking window absorption (CXL-WA). CXL-WA was performed when the infection did not respond to systemic and topical antibiotic therapy. The protocol entails the use of hypoosmolar riboflavin before the irradiation with UV-A, and the penetration is obtained through the epithelial defect overlying the ulcer. RESULTS:: In all cases, CXL halted the progression of the ulcer. After a minimum follow-up of 3 months, none of the patients had recurrence of the infection. CONCLUSION:: CXL-WA is a promising technique of treatment of infectious corneal ulcers, delaying or preventing more invasive approaches. Copyright © 2012 by Lippincott Williams Wilkins.--------------------------------------------------------------------------------Reaxys Database Information|

Corneal Collagen Cross-Linking Window Absorption

Mario Romano;Vinciguerra P.
2013

Abstract

AbstractPURPOSE:: To evaluate the safety and efficacy of treatment of severe infectious corneal ulcers with hypoosmolar riboflavin solution and UV-A collagen cross-linking (CXL) without deepithelizing the cornea. METHODS:: Four eyes of 3 patients with severe keratitis and associated corneal melting, were treated with a new protocol of corneal CXL for infectious keratitis, named cross-linking window absorption (CXL-WA). CXL-WA was performed when the infection did not respond to systemic and topical antibiotic therapy. The protocol entails the use of hypoosmolar riboflavin before the irradiation with UV-A, and the penetration is obtained through the epithelial defect overlying the ulcer. RESULTS:: In all cases, CXL halted the progression of the ulcer. After a minimum follow-up of 3 months, none of the patients had recurrence of the infection. CONCLUSION:: CXL-WA is a promising technique of treatment of infectious corneal ulcers, delaying or preventing more invasive approaches. Copyright © 2012 by Lippincott Williams Wilkins.--------------------------------------------------------------------------------Reaxys Database Information|
File in questo prodotto:
File Dimensione Formato  
Corneal-collagen-cross-linking-window-absorption_2013_Cornea.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 384.92 kB
Formato Adobe PDF
384.92 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11699/3371
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact